Obesity and ovarian cancer: The silent link every woman needs to know
As obesity is increasing worldwide, its association with ovarian cancer has become increasingly prominent for prevention, early detection, and better therapeutic results.
The growing obesity burden
Obesity, which is a body mass index (BMI) of ≥30 kg/m², has become an epidemic in all parts of the globe. The World Health Organization (WHO) states:
Over 1 billion people in the world were obese in 2022.
Adult obesity in the US was 42.4% as of 2020, which is a steep rise from 30.5% in 2000 (CDC).
The trend is strongly relevant to cancer incidence, including ovarian cancer.
Ovarian cancer: The silent killer
Ovarian cancer is the fifth most common reason for female cancer-related deaths in the United States and is responsible for more female reproductive cancer deaths than any other type. The American Cancer Society estimates:
In 2024, an estimated 19,680 women in the United States will develop ovarian cancer.
About 12,740 deaths will occur due to the disease.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Top Australian Doctors Stunned By New German Hearing Aid That Costs Less Than Dinner Out
Top Trending News Today
Learn More
Undo
The five-year survival rate for ovarian cancer is typically low, just 49%, largely because it is typically diagnosed late.
Biological mechanisms that connect obesity and ovarian cancer
1. Overproduction of estrogen
Excess fat tissue results in peripheral conversion of androgens to estrogens, particularly after menopause. Estrogen stimulates growth in cells of the ovary, potentially increasing the chance of mutation and tumor formation.
2. Inflammation
Obesity causes chronic inflammation with elevated cytokine levels, including TNF-α, IL-6, and CRP.
Chronic inflammation results in DNA damage and may cause tumor development.
3. Insulin Resistance and IGF-1
Obesity is associated with insulin resistance, leading to raised levels of insulin and insulin-like growth factor-1 (IGF-1). Both exhibit mitogenic and anti-apoptotic properties, which may promote the survival and growth of ovarian tumor cells.
4. Adipokines and Leptin
Adipokines are hormones secreted by fat tissue. Among them, leptin is increased in obesity and has been reported to promote proliferation of cancer cells and ovarian tumor angiogenesis.
Epidemiological evidence
Multiple large-scale studies have measured the association of BMI and risk of ovarian cancer:
A meta-analysis in Cancer (2013) of more than 20 cohort studies concluded that an increase of 5 units in BMI was linked to a 10% higher risk of ovarian cancer.
A WCRF study found that increased body fatness is "likely" to be a cause of ovarian cancer, particularly for non-serous subtypes.
Obese ovarian cancer patients also experience worse prognosis, including:
Increased disease recurrence following treatment.
Decreased overall survival, with stage and treatment type controlled for.
Increased rates of surgery and chemotherapy complications.
Implications for Prevention and Management
From evidence, obesity is a modifiable risk factor for ovarian cancer. Prevention measures are:
Diet and exercise weight control.
Public health prevention policies against obesity from a young age.
Risk stratification and screening of high-BMI groups.
In practice, oncologists will have to modify the treatment of obese patients, including individualized chemotherapy dosing and more aggressive surgery to improve outcomes.
Obesity is not just a cosmetic issue—it is a clinical and biological risk factor and progression driver for ovarian cancer. As the epidemic of obesity marches forward, so must the need to incorporate prevention, awareness, and targeted treatment strategies into women's health policy. Prevention of obesity has the potential to dramatically decrease the burden of ovarian cancer and enhance survival in thousands of women worldwide.
Dr Vishnu Agarwal, Surgical Oncologist, Saifee Hospital, Mumbai
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
an hour ago
- Time of India
State's health system ‘cracking at every joint', says UDF report
T'puram: Kerala's vaunted "people-centred" health system is "cracking at every joint", warns a report submitted by the UDF health sub-committee chaired by senior IUML leader M K Muneer and consisting of representatives from all UDF constituents. The 23-page document billed as an effort to "reinvent the real Kerala model" accuses the state govt of presiding over a cascade of drug shortages, failed missions and stalled upgrades that left ordinary patients footing private bills for everything from sutures to MRI scans. The report says the flagship Aardram Mission, launched in 2016 to convert 846 primary health centres into family health centres, "plateaued after phase one" only 170 PHCs were upgraded, most without the promised extra nurses, pharmacists, or lab staff. Evening OP hours attract only token footfall, while the PHC reclassification drained the workforce from taluk and district hospitals, leaving them understaffed and overburdened. These secondary facilities, the report notes, still operate with a 1964-era staffing pattern. The tertiary sector too, the report says, is "building-rich and staff-poor". Several KIIFB-funded hospital blocks are lying unused due to the absence of sanctioned doctors, nurses or technicians. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like This Could Be the Best Time to Trade Gold in 5 Years IC Markets Learn More Undo Cath labs installed in district hospitals with the intent of reducing the load on medical college hospitals remain idle or function only in limited shifts. Drug procurement once considered a Kerala success story is now in disarray. The state-run Kerala medical services corporation Ltd (KMSCL) owes pharmaceutical companies Rs 695cr, prompting firms to cut deliveries by more than half. Kozhikode medical college alone has Rs 90cr pending, while the govt owes hospital development societies Rs 240cr in reimbursements. At Thiruvananthapuram medical college, patients wait over six months for MRI or CT scans as machines remain defunct for most of the week. Meanwhile, a vigilance probe into nepotism and irregular appointments at SAT Hospital has dragged on for two years without conclusion. The report recounts an incident where a caesarean section was performed under mobile torchlight due to a power outage, calling it symbolic of how far the system has fallen. S chemes once flagged as Kerala's health innovations now lie in tatters. The Hridyam programme for paediatric heart surgery and Aarogya Kiranam, which guarantees free treatment to children under 18, have both been crippled by fund shortages. The cochlear implant scheme Shruthi Tharangam, which helped over 630 children during the UDF era, has virtually stalled, leaving broken processors unrepaired for years. Even as lifestyle diseases rise and non-communicable conditions take hold of a growing population, a large-scale NCD screening programme initiated with great fanfare has fizzled out after baseline surveys. The committee warns that dengue, rabies, H1N1 and new outbreaks like Nipah are testing the state's threadbare vector control system. Post-Covid, most PHCs have pivoted entirely to curative functions, with prevention now reduced to slogans. Emergency care is no better. Ambulance crashes rose to 193 in 2022, with 130 deaths over four years. Marginalized groups have been left behind. Despite Kerala preparing a transgender policy in 2014, no medical college has gender clinics or surgery infrastructure. Tribal areas suffer shockingly high infant mortality and birth-weight deficits Attapadi's average newborn weight is 1.5kg compared to the state's 2.8kg. Endosulfan victims in Kasaragod, officially listed at 6,727, still lack specialist care and rely on neighbouring Karnataka for treatment. The committee urges the govt to clear all dues to drug suppliers, fix accountability for failed schemes, immediately operationalise unused facilities and restore core public health functions like surveillance and disease prevention. "The myth of an unassailable Kerala model is over," the report concludes.
Time of India
4 hours ago
- Time of India
Seed production agreement for advanced ‘bhindi' variety signed
1 2 Varanasi: On the occasion of the 97th Foundation Day of the Indian Council of Agricultural Research (ICAR), an agreement for seed production of the advanced okra (bhindi) variety 'Kashi Sahishnu' was signed between the Indian Institute of Vegetable Research (IIVR), Varanasi, and Ador Seeds India Private Limited, Pune. The agreement was facilitated through CEO of ICAR's company AgriInnovate, Praveen Malik, in a ceremony held in the presence of Union Minister of Agriculture & Farmers Welfare and Rural Development Shivraj Singh Chouhan and director general of ICAR & Secretary, Agricultural Education and Research ML Jat in New Delhi on Thursday. IIVR director Rajesh Kumar signed the technology transfer documents with the CEO Malik and exchanged them. Under this partnership, India's leading seed production company can now produce seeds of this advanced okra variety and directly reach farmers in Uttar Pradesh, Bihar, Jharkhand, and Punjab. According to Pradeep Karmakar, the breeder scientist of this advanced variety, 'Kashi Sahishnu' (VRO-111) is recommended for cultivation in the four agricultural zones, including Punjab, Uttar Pradesh, Bihar, and Jharkhand, and is notified under gazette notification number SO 1362 (E) dated March 12, 2024. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Is it legal? How to get Internet without paying a subscription? Techno Mag Learn More Undo The IIVR director said that years of relentless scientific effort went into developing this variety. Along with intensive research by scientists, repeated field demonstrations and the special role of the Institute's Technology Management Unit (ITMU) were crucial. "Kashi Sahishnu variety is extremely beneficial for farmers because it is resistant to two major viral diseases, which will require farmers to use fewer pesticides and reduce production costs," he said, adding that due to its higher productivity, farmers' income can increase by 20-23%. According to him, considering the commercial benefits of this okra variety, several other companies have also applied for its license, which are being considered. Nagendra Rai, head of the Crop Improvement Division, said that due to the better fruit quality of this variety, farmers will get good prices in the market, and labour costs will also be reduced due to ease in harvesting and packing.
Time of India
4 hours ago
- Time of India
CSIR to launch Rs 100 sickle cell anaemia test kit in 6 months
Pune: The Council of Scientific and Industrial Research (CSIR) will launch an affordable screening test kit for sickle cell anaemia in six months. The PCR-based test kit, which would be priced under Rs 100, has been developed by the Centre for Cellular and Molecular Biology — a laboratory under CSIR. CSIR director-general N Kalaiselvi, who inaugurated a conference in the city on Friday, shared this development. Speaking on the sidelines of the National Scientists Round Table Conference 2025 at MIT World Peace University, she said the test, using one drop of blood, can screen patients for the disease in less than 30 minutes. 'Many research institutes, including ICMR and CSIR, have worked on this kit. With just a drop of blood put in a polymerase chain reaction test (PCR) kit developed by CSIR; one can understand in 20-30 minutes whether an individual is a patient, a carrier, or at risk of contracting sickle cell anaemia,' Kalaiselvi said. You Can Also Check: Pune AQI | Weather in Pune | Bank Holidays in Pune | Public Holidays in Pune She said the test will cost between Rs 87 and Rs 93, and will be available on the Union govt's Govt e-Marketplace (GeM) portal. On AI in healthcare Kalaiselvi said the integration of artificial intelligence (AI) in many of CSIR's labs in India could be a gamechanger; she said AI will be a very helpful addition to the healthcare sector. The CSIR director-general also touched upon the trend of scientists being encouraged to establish their own startups. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 11 Foods That Help In Healing Knee Pain Naturally Undo She said in India, senior scientists or principal investigators often encourage younger colleagues to launch their own startups. 'This is how spin-off startups have begun in India, and scientists are moving in that direction in a big way. Youngsters have that fire in the belly; they want to have their own startups, so they will be the driving force,' she said. 'As India marches toward its 2047 (Viksit Bharat) vision, it's clear that science, technology, and innovation will be the real engines of national growth. What's truly inspiring is the mindset shift among students; they're not just seeking jobs, they're building startups and creating employment. This silent revolution is made possible through science and must be nurtured,' she added. The conference will host 36 Shanti Swarup Bhatnagar and INSA awardees, directors of premier national and regional laboratories, eminent academicians, and senior scientists from across diverse research and industrial sectors.
